Pancreatic Cancer Research

ResearcherHonorHealthActive in the last 2 years

Albert Amini

Matched on OpenAlex author ID A5112284660. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. A phase II clinical trial of albumin-bound paclitaxel, cisplatin, gemcitabine (NABPLAGEM), and paricalcitol as neoadjuvant therapy in pancreatic cancer. Co-author DOI 10.1093/oncolo/oyag232↗
  2. Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions. Co-author DOI 10.1186/s13073-020-00776-9↗
  3. Neo-adjuvant therapy for pancreatic cancer: hope for the future. Last author DOI 10.1080/17474124.2019.1607294↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Erkut Hasan Borazanci · 3 shared papers, 2019–2026 · strength 0.48
  2. Gayle Jameson · 2 shared papers, 2020–2026 · strength 0.32
  3. Daniel D. Von Hoff · 2 shared papers, 2020–2026 · strength 0.32
  4. Alexa F. Viniotis · 1 shared paper, 2026 · strength 0.22
  5. Ronald Lee Korn · 1 shared paper, 2026 · strength 0.22
  6. Syed Rahmanuddin · 1 shared paper, 2026 · strength 0.22
  7. Ronald M. Evans · 1 shared paper, 2026 · strength 0.22
  8. Pawan Noel · 1 shared paper, 2020 · strength 0.09
  9. Derek Cridebring · 1 shared paper, 2020 · strength 0.09
  10. Jin Seok Heo · 1 shared paper, 2020 · strength 0.09
  11. In Woong Han · 1 shared paper, 2020 · strength 0.09
  12. Yanghee Woo · 1 shared paper, 2020 · strength 0.09
  13. Wei Lin · 1 shared paper, 2020 · strength 0.09
  14. Yuman Fong · 1 shared paper, 2020 · strength 0.09
  15. Haiyong Han · 1 shared paper, 2020 · strength 0.09
  16. Joon Oh Park · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.